Novosound earns patent for wearable ultrasound that monitors blood pressure

Scottish health tech company Novosound has secured a patent for its ultrasonic instrumentation system, marking its 21st patent since 2018. 

The patent is for a wearable ultrasound, strapped onto the body to produce images on mobile devices, such as tablets and smartphones. In the patented use case, the device is secured to a patient for constant monitoring of blood flow and pressure.

Earning the patent allows Novosound to engage in research and development contracts for consumer digital health applications The patent also grants the company exclusive rights to sell the technology while continuing research and pilot projects with major tech companies and healthcare institutions. 

In a statement, Novosound says it is partnering with the Texas Medical Center to further develop use cases and improvements for its ultrasound wearables.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup